Pyruvate kinase in human brain tumours. Its significance in the treatment of gliomas. 1982

C W van Veelen, and H Verbiest, and K J Zülch, and B van Ketel, and M J van der Vlist, and A M Vlug, and G Rijksen, and G E Staal

UI MeSH Term Description Entries
D007223 Infant A child between 1 and 23 months of age. Infants
D007231 Infant, Newborn An infant during the first 28 days after birth. Neonate,Newborns,Infants, Newborn,Neonates,Newborn,Newborn Infant,Newborn Infants
D007527 Isoenzymes Structurally related forms of an enzyme. Each isoenzyme has the same mechanism and classification, but differs in its chemical, physical, or immunological characteristics. Alloenzyme,Allozyme,Isoenzyme,Isozyme,Isozymes,Alloenzymes,Allozymes
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011770 Pyruvate Kinase ATP:pyruvate 2-O-phosphotransferase. A phosphotransferase that catalyzes reversibly the phosphorylation of pyruvate to phosphoenolpyruvate in the presence of ATP. It has four isozymes (L, R, M1, and M2). Deficiency of the enzyme results in hemolytic anemia. EC 2.7.1.40. L-Type Pyruvate Kinase,M-Type Pyruvate Kinase,M1-Type Pyruvate Kinase,M2-Type Pyruvate Kinase,Pyruvate Kinase L,R-Type Pyruvate Kinase,L Type Pyruvate Kinase,M Type Pyruvate Kinase,M1 Type Pyruvate Kinase,M2 Type Pyruvate Kinase,Pyruvate Kinase, L-Type,Pyruvate Kinase, M-Type,Pyruvate Kinase, M1-Type,Pyruvate Kinase, M2-Type,Pyruvate Kinase, R-Type,R Type Pyruvate Kinase
D001921 Brain The part of CENTRAL NERVOUS SYSTEM that is contained within the skull (CRANIUM). Arising from the NEURAL TUBE, the embryonic brain is comprised of three major parts including PROSENCEPHALON (the forebrain); MESENCEPHALON (the midbrain); and RHOMBENCEPHALON (the hindbrain). The developed brain consists of CEREBRUM; CEREBELLUM; and other structures in the BRAIN STEM. Encephalon
D001932 Brain Neoplasms Neoplasms of the intracranial components of the central nervous system, including the cerebral hemispheres, basal ganglia, hypothalamus, thalamus, brain stem, and cerebellum. Brain neoplasms are subdivided into primary (originating from brain tissue) and secondary (i.e., metastatic) forms. Primary neoplasms are subdivided into benign and malignant forms. In general, brain tumors may also be classified by age of onset, histologic type, or presenting location in the brain. Brain Cancer,Brain Metastases,Brain Tumors,Cancer of Brain,Malignant Primary Brain Tumors,Neoplasms, Intracranial,Benign Neoplasms, Brain,Brain Neoplasm, Primary,Brain Neoplasms, Benign,Brain Neoplasms, Malignant,Brain Neoplasms, Malignant, Primary,Brain Neoplasms, Primary Malignant,Brain Tumor, Primary,Brain Tumor, Recurrent,Cancer of the Brain,Intracranial Neoplasms,Malignant Neoplasms, Brain,Malignant Primary Brain Neoplasms,Neoplasms, Brain,Neoplasms, Brain, Benign,Neoplasms, Brain, Malignant,Neoplasms, Brain, Primary,Primary Brain Neoplasms,Primary Malignant Brain Neoplasms,Primary Malignant Brain Tumors,Benign Brain Neoplasm,Benign Brain Neoplasms,Benign Neoplasm, Brain,Brain Benign Neoplasm,Brain Benign Neoplasms,Brain Cancers,Brain Malignant Neoplasm,Brain Malignant Neoplasms,Brain Metastase,Brain Neoplasm,Brain Neoplasm, Benign,Brain Neoplasm, Malignant,Brain Neoplasms, Primary,Brain Tumor,Brain Tumors, Recurrent,Cancer, Brain,Intracranial Neoplasm,Malignant Brain Neoplasm,Malignant Brain Neoplasms,Malignant Neoplasm, Brain,Neoplasm, Brain,Neoplasm, Intracranial,Primary Brain Neoplasm,Primary Brain Tumor,Primary Brain Tumors,Recurrent Brain Tumor,Recurrent Brain Tumors,Tumor, Brain
D002471 Cell Transformation, Neoplastic Cell changes manifested by escape from control mechanisms, increased growth potential, alterations in the cell surface, karyotypic abnormalities, morphological and biochemical deviations from the norm, and other attributes conferring the ability to invade, metastasize, and kill. Neoplastic Transformation, Cell,Neoplastic Cell Transformation,Transformation, Neoplastic Cell,Tumorigenic Transformation,Cell Neoplastic Transformation,Cell Neoplastic Transformations,Cell Transformations, Neoplastic,Neoplastic Cell Transformations,Neoplastic Transformations, Cell,Transformation, Cell Neoplastic,Transformation, Tumorigenic,Transformations, Cell Neoplastic,Transformations, Neoplastic Cell,Transformations, Tumorigenic,Tumorigenic Transformations
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children

Related Publications

C W van Veelen, and H Verbiest, and K J Zülch, and B van Ketel, and M J van der Vlist, and A M Vlug, and G Rijksen, and G E Staal
January 1988, British journal of neurosurgery,
C W van Veelen, and H Verbiest, and K J Zülch, and B van Ketel, and M J van der Vlist, and A M Vlug, and G Rijksen, and G E Staal
December 1973, FEBS letters,
C W van Veelen, and H Verbiest, and K J Zülch, and B van Ketel, and M J van der Vlist, and A M Vlug, and G Rijksen, and G E Staal
January 2004, Ai zheng = Aizheng = Chinese journal of cancer,
C W van Veelen, and H Verbiest, and K J Zülch, and B van Ketel, and M J van der Vlist, and A M Vlug, and G Rijksen, and G E Staal
January 1986, Acta neurochirurgica,
C W van Veelen, and H Verbiest, and K J Zülch, and B van Ketel, and M J van der Vlist, and A M Vlug, and G Rijksen, and G E Staal
May 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology,
C W van Veelen, and H Verbiest, and K J Zülch, and B van Ketel, and M J van der Vlist, and A M Vlug, and G Rijksen, and G E Staal
August 1990, Cancer research,
C W van Veelen, and H Verbiest, and K J Zülch, and B van Ketel, and M J van der Vlist, and A M Vlug, and G Rijksen, and G E Staal
December 2023, Hematology. American Society of Hematology. Education Program,
C W van Veelen, and H Verbiest, and K J Zülch, and B van Ketel, and M J van der Vlist, and A M Vlug, and G Rijksen, and G E Staal
February 1977, Proceedings of the National Academy of Sciences of the United States of America,
C W van Veelen, and H Verbiest, and K J Zülch, and B van Ketel, and M J van der Vlist, and A M Vlug, and G Rijksen, and G E Staal
January 1971, Biochimica et biophysica acta,
C W van Veelen, and H Verbiest, and K J Zülch, and B van Ketel, and M J van der Vlist, and A M Vlug, and G Rijksen, and G E Staal
December 1989, Nihon rinsho. Japanese journal of clinical medicine,
Copied contents to your clipboard!